- Home
- EYPT vs REAL Comparison
EYPT vs REAL Comparison
Compare EYPT & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- REAL
- Stock Information
- Founded
- EYPT N/A
- REAL 2011
- Country
- EYPT
- REAL United States
- Employees
- EYPT N/A
- REAL N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- REAL Other Specialty Stores
- Sector
- EYPT Industrials
- REAL Consumer Discretionary
- Exchange
- EYPT Nasdaq
- REAL Nasdaq
- Market Cap
- EYPT 741.0M
- REAL 871.2M
- IPO Year
- EYPT N/A
- REAL 2019
- Fundamental
- Price
- EYPT $14.01
- REAL $8.67
- Analyst Decision
- EYPT
- REAL Buy
- Analyst Count
- EYPT 0
- REAL 4
- Target Price
- EYPT N/A
- REAL $11.13
- AVG Volume (30 Days)
- EYPT 659.8K
- REAL 4.5M
- Earning Date
- EYPT 08-06-2025
- REAL 11-03-2025
- Dividend Yield
- EYPT N/A
- REAL N/A
- EPS Growth
- EYPT N/A
- REAL N/A
- EPS
- EYPT N/A
- REAL N/A
- Revenue
- EYPT $51,898,000.00
- REAL $636,971,000.00
- Revenue This Year
- EYPT N/A
- REAL $14.27
- Revenue Next Year
- EYPT N/A
- REAL $9.94
- P/E Ratio
- EYPT N/A
- REAL N/A
- Revenue Growth
- EYPT 2.99
- REAL 12.68
- 52 Week Low
- EYPT $3.91
- REAL $2.24
- 52 Week High
- EYPT $14.37
- REAL $11.38
- Technical
- Relative Strength Index (RSI)
- EYPT 77.25
- REAL 71.33
- Support Level
- EYPT $11.38
- REAL $7.30
- Resistance Level
- EYPT $12.24
- REAL $8.00
- Average True Range (ATR)
- EYPT 0.74
- REAL 0.41
- MACD
- EYPT 0.13
- REAL 0.04
- Stochastic Oscillator
- EYPT 89.80
- REAL 88.67
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.